450 related articles for article (PubMed ID: 27977429)
21. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J
J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079
[TBL] [Abstract][Full Text] [Related]
22. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
23. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acids and cognitive decline: a systematic review.
Martí Del Moral A; Fortique F
Nutr Hosp; 2019 Aug; 36(4):939-949. PubMed ID: 31215788
[TBL] [Abstract][Full Text] [Related]
25. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
[TBL] [Abstract][Full Text] [Related]
26. Omega 3 fatty acids and cognitive health in older people.
Dangour AD; Andreeva VA; Sydenham E; Uauy R
Br J Nutr; 2012 Jun; 107 Suppl 2():S152-8. PubMed ID: 22591889
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
Pauwels EK; Volterrani D; Mariani G; Kairemo K
Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
[TBL] [Abstract][Full Text] [Related]
28. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
[TBL] [Abstract][Full Text] [Related]
29. An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention.
Castellanos-Perilla N; Borda MG; Aarsland D; Barreto GE
Expert Rev Neurother; 2024 Mar; 24(3):313-324. PubMed ID: 38379273
[TBL] [Abstract][Full Text] [Related]
30. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
[TBL] [Abstract][Full Text] [Related]
31. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.
Külzow N; Witte AV; Kerti L; Grittner U; Schuchardt JP; Hahn A; Flöel A
J Alzheimers Dis; 2016; 51(3):713-25. PubMed ID: 26890759
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the Cochrane Review: Omega-3 Fatty Acids for the Treatment of Dementia. Cochrane Database Syst Rev. 2016;4:CD009002.].
Cordeiro Sousa D; Ferreira Dos Santos G; Costa J; Vaz-Carneiro A
Acta Med Port; 2017 Oct; 30(10):671-674. PubMed ID: 29268059
[TBL] [Abstract][Full Text] [Related]
33. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).
Giudici KV; de Souto Barreto P; Beard J; Cantet C; Araujo de Carvalho I; Rolland Y; Vellas B;
Maturitas; 2020 Nov; 141():39-45. PubMed ID: 33036701
[TBL] [Abstract][Full Text] [Related]
34. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia.
Knöchel C; Voss M; Gruter F; Alves GS; Matura S; Sepanski B; Stablein M; Kraft D; Prvulovic D; Carvalho AF; Reif A; Oertel-Knochel V
Curr Alzheimer Res; 2017; 14(3):240-254. PubMed ID: 27335040
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
Kidd PM
Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
[TBL] [Abstract][Full Text] [Related]
37. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis.
Hooijmans CR; Pasker-de Jong PC; de Vries RB; Ritskes-Hoitinga M
J Alzheimers Dis; 2012; 28(1):191-209. PubMed ID: 22002791
[TBL] [Abstract][Full Text] [Related]
38. Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review.
Kakutani S; Watanabe H; Murayama N
Nutrients; 2019 May; 11(5):. PubMed ID: 31137655
[TBL] [Abstract][Full Text] [Related]
39. PUFA for prevention and treatment of dementia?
Carrié I; Abellan Van Kan G; Rolland Y; Gillette-Guyonnet S; Vellas B
Curr Pharm Des; 2009; 15(36):4173-85. PubMed ID: 20041819
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
